Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neumega and G-CSF for PBSC Mobilization
NCT00004157Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Aug 2000
- Primary completion
- Apr 2002
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of oprelvekin in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), breast cancer, gestational trophoblastic tumor (GTN), kidney cancer, sponsored by Fred Hutchinson Cancer Center. Started Aug 2000; status: completed.
02
Drugs
oprelvekin
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)breast cancergestational trophoblastic tumor (GTN)kidney cancer
Beyond the preview
Go deeper on NCT00004157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004157.